Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C147 - Neuromyelitis Optica Spectrum Disorders

Thursday 04/07/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Dean M. Wingerchuk, MD, FAAN
Multiple Sclerosis
Upon completion of this course, participants should be able to describe clinical presentation of NMOSD; discuss diagnostic criteria for NMOSD; compare and contrast clinical features of NMOSD with common diseases that mimic NMOSD; be familiar with the imaging characteristics of NMOSD; and discuss approved treatment options for NMOSD.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:45 AM PDT Speaker NMOSD: Diagnostic Issues
Cristina Valencia Sanchez, MD
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Dean M. Wingerchuk, MD, FAAN
07:45 AM - 08:30 AM PDT Speaker NMOSD: Treatment Issues
Dean M. Wingerchuk, MD, FAAN
08:30 AM - 09:00 AM PDT Speaker Case-Based Discussions
Dean M. Wingerchuk, MD, FAAN, Cristina Valencia Sanchez, MD
Faculty Disclosures
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TTY Biopharm. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Biopharm. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Cristina Valencia Sanchez, MD Dr. Valencia Sanchez has nothing to disclose.